home / stock / bmrn / bmrn news


BMRN News and Press, BioMarin Pharmaceutical Inc. From 02/03/26

Stock Information

Company Name: BioMarin Pharmaceutical Inc.
Stock Symbol: BMRN
Market: NASDAQ
Website: bmrn.com

Menu

Get BMRN Alerts

News, Short Squeeze, Breakout and More Instantly...

BMRN - Xeris Biopharma: Strong Recorlev Momentum And Pipeline Opportunity

2026-02-03 08:52:33 ET Xeris Pharmaceuticals' ( XERS ) shares have surged nearly 100% year-over-year (YoY) as a result of both strong and accelerating commercial revenue growth, improving operational discipline, and positive results from its pipeline. Today, Xeris represents mor...

BMRN - The Right Play On BioMarin Pharmaceuticals

2026-02-01 06:17:13 ET Shares of rare disease concern BioMarin Pharmaceuticals Inc. ( BMRN ) initially rallied nicely after announcing its intention to acquire model portfolio holding Amicus Therapeutics ( FOLD ) for $4.8 billion on December 19th. The acquisition deliver...

BMRN - Should You Buy BioMarin Pharmaceutical Before Feb. 18?

2026-01-31 05:04:00 ET BioMarin Pharmaceutical 's (NASDAQ: BMRN) website doesn't show any scheduled events on its calendar over the next month. However, that means nothing. The drugmaker will almost certainly report its 2025 full-year and fourth-quarter results in the coming weeks. ...

BMRN - BioMarin prices $850M senior notes, completes $2B term loan syndication

2026-01-29 16:15:49 ET More on BioMarin Pharmaceutical 44th Annual J.P. Morgan Healthcare Conference BioMarin Pharmaceutical Inc. (BMRN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript BioMarin Acquiring Amicus -- Both Great Companies, Only One W...

BMRN - BioMarin Announces Pricing of Private Offering of Senior Notes and Completion of Syndication of New Senior Secured Term Loan Facility

BioMarin Announces Pricing of Private Offering of Senior Notes and Completion of Syndication of New Senior Secured Term Loan Facility PR Newswire SAN RAFAEL, Calif. , Jan. 29, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ("BioMarin") announced today that i...

BMRN - BioMarin offers $850M senior notes and syndication of a new senior secured term loan facility to fund acquisition

2026-01-26 07:57:44 ET More on BioMarin Pharmaceutical 44th Annual J.P. Morgan Healthcare Conference BioMarin Pharmaceutical Inc. (BMRN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript BioMarin Acquiring Amicus -- Both Great Companies, Only One W...

BMRN - BioMarin Announces Proposed Private Offering of Senior Notes and Syndication of New Senior Secured Term Loan Facility

BioMarin Announces Proposed Private Offering of Senior Notes and Syndication of New Senior Secured Term Loan Facility PR Newswire SAN RAFAEL, Calif. , Jan. 26, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ("BioMarin") announced today that it intends to off...

BMRN - Mega-to-large cap healthcare stocks with the weakest earnings momentum

2026-01-16 14:18:10 ET More on healthcare stocks XLV Vs. BME: Total Return Or Income, Which Healthcare Strategy Wins? IYH: Elevated Valuations And Slowing Growth Signal Subpar 2026 Returns Baxter International Inc. (BAX) Presents at 44th Annual J.P. Morgan Healthcare...

BMRN - BioMarin Pharmaceutical Inc. (BMRN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-12 18:25:57 ET BioMarin Pharmaceutical Inc. (BMRN) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 2:15 PM EST... Read the full article on Seeking Alpha For further details see: BioMarin Pharmaceutical Inc. (BMRN) Presents at 44th Annual J.P. Morgan He...

BMRN - BioMarin Appoints Arpit Davé Chief Digital and Information Officer

BioMarin Appoints Arpit Davé Chief Digital and Information Officer PR Newswire Mr. Davé Brings more than 20 Years of Experience in Creating Enterprise Value through Digital Transformation, Information Technology and Artificial Intelligence across the Biopharmaceutical Ind...

Previous 10 Next 10